oncolytic adenovirus therapy carrying membrane-anchored IL-12 variants (University of Navarra)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameoncolytic adenovirus therapy carrying membrane-anchored IL-12 variants (University of Navarra)
Drug Alias NameN/A
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterleukin-12 receptor stimulants
TargetsInterleukin-12 receptor
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Navarra
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Navarra
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A